Detalhe da pesquisa
1.
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study.
Clin Exp Rheumatol
; 41(7): 1463-1472, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36622132
2.
Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
Clin Exp Rheumatol
; 40(3): 551-559, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34001304
3.
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
Rheumatology (Oxford)
; 54(10): 1858-66, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26001633
4.
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Ann Rheum Dis
; 72(6): 844-50, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22739990
5.
Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT.
RMD Open
; 6(3)2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33051270
6.
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
JAMA
; 301(7): 737-44, 2009 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-19224750
7.
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
Arthritis Res Ther
; 18(1): 183, 2016 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27495156
8.
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
Patient Prefer Adherence
; 8: 1061-71, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25125973